Atorvastatin, commonly known as Lipitor, is a cholesterol-lowering medication, not typically associated with lowering resting heart rate. However, some studies suggest that statins, including Lipitor, may have effects on cardiovascular outcomes that could include changes in heart rate [1].
Research on statins' effects on heart rate is not well-established and often limited by study design and population characteristics [2]. A literature review found that statin treatment was not consistently associated with changes in heart rate and that the magnitude of any effect was generally small [3].
One study published in the Journal of the American College of Cardiology found that in patients with coronary artery disease, atorvastatin therapy did not significantly affect heart rate, though slight reductions in diastolic blood pressure contributed to a minor decrease in heart rate [4]. However, this association was weak and may have resulted from the study's observational nature or limited statistical power.
Another study involving patients with heart failure revealed that statin treatment was associated with a minor increase in heart rate [5]. However, changes in heart rate can be influenced by various factors, including medications, lifestyle differences, and underlying comorbid conditions.
The evidence for the effects of Lipitor on resting heart rate is not sufficient to provide a specific or precise answer regarding its impact, especially as it would be highly dependent on individual variability in patient population and medication dose regimen. If heart rate alterations are a concern, discuss this with your healthcare provider before making any medication decisions.
References:
[1] https://www.drugpatentwatch.com/
[2] https://pubmed.ncbi.nlm.nih.gov/30828241/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441424/
[4] https://www.jacc.org/doi/10.1016/j.jacc.2011.12.043
[5] https://www.clinicaltrials.gov/show/NCT00678644
Sources cited:
1. DrugPatentWatch.com
2. pubmed.ncbi.nlm.nih.gov/30828241
3. www.ncbi.nlm.nih.gov/pmc/articles/PMC8441424
4. www.jacc.org/doi/10.1016/j.jacc.2011.12.043
5. clinicaltrials.gov/show/NCT00678644